Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | syrosingopine | 19518 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | syrosingopine | 19518 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | syrosingopine | 19518 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | syrosingopine | 19518 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | syrosingopine | 19518 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | syrosingopine | 19518 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | syrosingopine | 19518 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | syrosingopine | 19518 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | syrosingopine | 19518 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | ellipticine | 3052 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | ellipticine | 3052 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | ellipticine | 3052 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | ellipticine | 3052 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | ellipticine | 3052 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | ellipticine | 3052 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ellipticine | 3052 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | ellipticine | 3052 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ellipticine | 3052 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | ellipticine | 3052 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | ellipticine | 3052 | drug-path |